-
- Form: Tablet
- Keep out of reach of children
- Store at room temperature
- In case of overdose call 1-800-222-1222
- Usually taken once or twice daily
- Dosage based on medical condition and response to therapy
- Allergic reaction unlikely
- Do not share with others
- Do not double dose
- Being investigated for use in other cancer types
- Novartis has a patient assistance program for those who need financial assistance covering drug costs
-
-
Gleevec is the brand name given to the drug Imatinib in the United States. In Europe and Australia, Imatinib goes by the name of Glivec. Imatinib is marketed by the company Novartis. Novartis chemists identified Imatinib in the late 1990s and Gleevec became FDA approved in May of 2001.
-
Proper use
Gleevec comes in tablet form and is taken by mouth with food and a full glass of water to minimize the chances of an upset stomach. Be sure to follow your doctor's orders of dosing when taking Gleevec. If you have trouble swallowing tablets you may dissolve them in a glass of water or apple juice. -
Disclaimer
The content in this page is not a substitute for professional medical advice. Please contact your doctor before taking Gleevec. -
-
Gleevec Questions
-
Are you familiar with any side affects such as fever by using Gleevec? 2 AnswersThe gleevec company's website lists the following side effects. --quote-- Common side effects of Gleevec A majority of patients with Ph+ CML or Kit+ GIST expe... read more
-





